Summary: The rapid advances of omics technologies have generated abundant genomic data in public repositories and effective analytical approaches are critical to fully decipher biological knowledge inside these data. Meta-analysis combines multiple studies of a related hypothesis to improve statistical power, accuracy and reproducibility beyond individual study analysis. To date, many transcriptomic meta-analysis methods have been developed, yet few thoughtful guidelines exist. Here, we introduce a comprehensive analytical pipeline and browser-based software suite, called MetaOmics, to meta-analyze multiple transcriptomic studies for various biological purposes, including quality control, differential expression analysis, pathway enrichment analysis, differential coexpression network analysis, prediction, clustering and dimension reduction. The pipeline includes many public as well as >10 in-house transcriptomic metaanalytic methods with data-driven and biological-aim-driven strategies, hands-on protocols, an intuitive user interface and step-by-step instructions.
Introduction
With the rapid advances of high-throughput "-omics" technologies in the past decades, production of various kinds of omics data has become affordable and prevalent. Large amounts of transcriptomic data have been generated using microarray or RNA sequencing platforms for different biological aims and have been stored in data repositories such as GEO, ArrayExpress and SRA. However, individual studies are often of small or moderate sample size, which yield limited statistical power and low reproducibility. The combination of multiple transcriptomic studies of a related hypothesis using meta-analysis has become an emerging and effective practice to improve statistical power, accuracy and generalizability in biological investigations. In existing transcriptomic metaanalysis publications, the project rationale, objectives and data inclusion/exclusion criteria are often vaguely reported, since the analyses are intended to be exploratory and assist further hypothesis generation. The data preprocessing procedures, such as gene matching, gene filtering and outlier detection/exclusion, are often ambiguous and irreproducible as well. For further information, see Tseng et al. (2012) for a detailed review. Figure S1 (A) shows the number of publications in PubMed related to "transcriptomic meta-analysis" each year, demonstrating its rapid development and wide application. Despite this popularity, a thoughtful analysis pipeline with step-by-step instructions and an intuitive interface for biologists to conveniently conduct data-driven investigations is lacking. In addition, existing omics meta-analyses often only focus on the detection of differentially expressed (DE) genes, pathways and network analysis, leaving many powerful statistical learning tools unexplored. For example, Integrative Array Analyzer (iArray) (Pan, et al., 2006) and NetworkAnalyst (Xia, et al., 2015) provided tools for conventional DE gene and pathway detection and network visualization. In this paper, we introduce a comprehensive analytical pipeline and browser-based software suite, called MetaOmics, to meta-analyze multiple transcriptomic studies for various biological purposes, including seven modules for quality control (MetaQC), differential expression analysis (MetaDE), pathway enrichment analysis (MetaPath), differential co-expression network analysis (MetaNetwork), classification analysis (MetaPredict), clustering analysis (MetaClust), and dimension reduction (MetaPCA) ( Figure S1 (B) (C)). The pipeline includes a large number of public and >10 in-house transcriptomic meta-analysis methods with biology-driven strategies and hands-on protocols. The modularized software structure of MetaOmics will allow for its future extension as new methodologies become available. Table S1 outlines the advantages and additional features compared to existing tools. Each of the seven analytical modules generates its own outputs, such as DE gene lists, pathway annotation, classification model or cluster assignment. MetaOmics also creates extensive visualization and diagnostic plots to assist users with selecting tuning parameters and/or interpreting the results. Post hoc analyses, such as external validation and functional annotation, are also included in the tool.The modules in MetaOmics can be creatively used in selected order to evaluate and understand the biological findings and generate further hypothesis. For example, MetaClust can first be used to cluster samples in multiple transcriptomic studies and identify disease subtypes. Based on the cluster assignment, disease subtypes of interest can be selected and MetaDE, MetaPath and MetaNetwork can then be used to investigate their DE genes, functional annotations and differential co-expression networks.
Case study and demonstration
In Supplement, we present comprehensive applications of the seven modules to three real applications using breast cancer, prostate cancer and leukemia datasets. Due to space limit, here we only discuss three selected modules using the breast cancer example. This case study contained four breast cancer datasets, including one RNA-seq study from TCGA and three microarray studies from GEO (GSE7390, GSE2034 and 
